Tenofovir disoproxil fumarate for multiple nucleos(t)ide analogues treatment failure hepatitis B: Is monotherapy enough?

BACKGROUND AND AIM: Tenofovir disoproxil fumarate (TDF) is a first‐line treatment for chronic hepatitis B virus (HBV) infection for its high potency and a low rate of drug resistance. This study investigated the efficacy and safety of TDF in Chinese patients with chronic hepatitis B (CHB) infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Xieer, Xie, Qing, Shang, Jia, Tang, Hong, Xu, Min, Meng, Qinghua, Zhang, Jiming, Gao, Pujun, Sheng, Jifang, Wang, Hao, Jia, Jidong, Wang, Guiqiang, Wu, Shunquan, Ping, Jingna, Hou, Jinlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303406/
https://www.ncbi.nlm.nih.gov/pubmed/34894002
http://dx.doi.org/10.1111/jgh.15757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303406/
https://www.ncbi.nlm.nih.gov/pubmed/34894002
http://dx.doi.org/10.1111/jgh.15757

Ejemplares similares